No abstract available.
Orgasm* ; Sexual Dysfunctions, Psychological*

Vaginismus is a sexual dysfunction which results from vaginal musculature spasm and makes the penetration almost impossible. It is commonly associated with significant emotional distress. On several occasions, fear of pain during sexual intercourse may perpetuate the sexual dysfunction. We report a case of primary vaginismus that was associated with psychiatric squeale of anxiety and depression psychopathology. It suggests that psychological problems related to a mentalhealth problem in vaginismus should be dealt adequately for a holistic approach. A combination of behavioural, psychological and pharmacological treatment is important to ensure a good prognosis outcome.
Vaginismus ; Sexual Dysfunctions, Psychological

OBJECTIVETo point out and define "insertion obstacle" (IO) as another sort of sexual dysfunction.

METHODSA retrospective review was done on 32 patients with IO. They were diagnosed by self-rating insertion scale(SIS) designed by reference to the first five questions in OLeary's "Brief Male Sexual Function Inventory for Urology" (1995), involving sexual desire and erection and insertion, and treated mainly by psychological behavior therapy.

RESULTSOf the 32 cases, 30 patients were diagnosed as IO, 29 (90.6%) were simple psychological IO, and successfully cured by psychological behavior therapy.

CONCLUSIONSIO, as a sort of sexual dysfunction, could be diagnosed by SIS, and cured by psychological behavior therapy.

OBJECTIVETo investigate the interventional effect of comprehensive behaviour psychotherapy on the ejaculatory latency of premature ejaculation (PE) patients, sexual satisfaction of sexual partners, as well as its influence on the results of clinical treatment.

METHODSNinety PE patients were randomly divided into a psychological intervention group (n = 45) and a control group (n = 45). Both groups were given medicine therapy, and the former also received comprehensive behaviour psychotherapy for 6 weeks. All the patients were assessed with the Chinese index of sexual function for PE and ejaculatory latency in the vagina, and the clinical efficacy was compared between the two groups.

RESULTSBefore treatment, the ejaculatory latency in the vagina was (0.69 +/- 0.25) min and (0.71 +/- 0.19) min respectively in the intervention and the control groups, as compared with (5.87 +/- 0.59) min and (4.76 +/- 0.54) min before treatment, with significant difference (P < 0.01). In the intervention group, the scores in the control of ejaculatory reflex, the sexual satisfaction of the patients and their sexual partners and anxiety or depress in sexual activity in CIPE were higher than in the control group, with significant difference between the two groups (t = 2.12, 2.31, 2.01, 2.24, P < 0.05). The difference in the SAS score after therapy was of significance (P < 0.01). A month after treatment, the effectivity rates of the two groups were 82.9% and 30% respectively, and the difference was significant (P < .01).

CONCLUSIONComprehensive behaviour psychotherapy obviously adds to the clinical efficacy of drugs in the treatment of PE.

Premature ejaculation (PE) is a most common sexual dysfunction in males, which variably affects men's reproductive and mental health. Recent studies show that PE affects not only the patients themselves, but also the psychological state of their spouses, which, in turn, may alleviate or aggravate the patients'PE symptoms by different reactions. However, the correlation between PE and female's psychological factors is mostly ignored by the patients and even clinicians in the studies, diagnosis and treatment of PE.
Female ; Humans ; Male ; Sexual Dysfunction, Physiological ; psychology ; Sexual Dysfunctions, Psychological ; etiology ; Sexual Partners ; psychology ; Spouses ; psychology

Recent years have seen great progress in the researches on the pharmacotherapy of female sexual dysfunction( FSD). Estrogen replacement therapy is effective on female sexual pain and dyspareunia; androgen can improve female hyposexuality; and a variety of drugs and medication forms are being studied for their efficacy on FSD, including the 5-phosphodiesterase inhibitor, dopamine receptor stimulant, prostaglandin E1, adrenergic receptor blocker, some traditional Chinese medicine, and so on, which have yielded lots of inspiring findings.
Drug Therapy ; methods ; trends ; Female ; Humans ; Sexual Dysfunction, Physiological ; drug therapy ; Sexual Dysfunctions, Psychological ; drug therapy

As one of the most common complaints in clinical setting, premature ejaculation (PE) is characterized by a very short intravaginal ejaculatory latency time (IELT), the inability to control or delay ejaculation and negative consequences (bother/distress). At present time, there is no universally accepted definition of PE, and the focus of the controversy on its definition is how to quantify IELT. A new proposal distinguishes PE into 4 categories: lifelong PE, acquired PE, natural variable PE and premature-like ejaculatory dysfunction. The difference in the underlying pathophysiology and etiology of different PE categories determines the first choice of treatment.
Ejaculation ; Humans ; Male ; Sexual Dysfunction, Physiological ; diagnosis ; therapy ; Sexual Dysfunctions, Psychological ; diagnosis ; therapy

Human sexuality has both its sociological nature and biological nature. Advances in molecular biology has unveiled almost all the biological mysteries of human sexuality. However, many problems in the psychological and sociological aspects have not yet been thoroughly studied. As a matter of fact, these psychological and sociological factors have much influence on sexuality than those biological ones. This paper briefly introduces some factors affecting male sexual psychology, including masturbation and other common sexual psychological dysfunctions.
Humans ; Male ; Masturbation ; psychology ; Sexual Behavior ; physiology ; psychology ; Sexual Dysfunctions, Psychological

INTRODUCTIONThe physiological changes that occur in menopause alter sexual function and affect well-being. Hormonal changes contribute significantly to reduced sexual function in older women and sexual dysfunction may well be amenable to treatment with exogenous hormones or other agents.

MATERIALS AND METHODSRelevant clinical studies were identified by a computerised literature search. The collated data were presented to fellow gynaecologists for review, analysis of results and discussion in a series of meetings dedicated to finding the best evidence in menopause management. The evidence was assessed and used to prepare guidelines around the management of women who are affected by sexual dysfunction in menopause.

RESULTSHormone therapy benefits many women who have dyspareunia related to vaginal atrophy, reduced libido and decreased satisfaction, particularly if these symptoms adversely affect their quality of life. Alternative agents such as tibolone and sildenafil citrate can be useful adjuncts.

CONCLUSIONSIt is increasingly important to recognise postmenopausal sexual dysfunction. Treatment of this syndrome must be individualised to the specific complaints of each woman. Hormones and other agents are relevant treatment options for properly-selected women.

PURPOSE: Female sexual dysfunction may have its origin in abnormal blood flow into the clitoris during sexual stimulation. There have been few studies to measure the clitoral blood flow by color duplex Doppler ultrasonography. The goal of this study was to evaluate the diagnostic values of clitoral color duplex Doppler ultrasonography with audiovisual sexual stimulation (AVSS). MATERIALS AND METHODS: Clitoral color duplex Doppler ultrasonography was performed during AVSS with glasses-type monitor. A total of fourteen women were included in the study; five premenopausal volunteers (mean age; 35, range; 24-50), five sexual arousal disorder patients (mean age; 38, range; 31-45) and four menopausal volunteers (mean age; 53, range; 47-56). Peak systolic velocity (PSV), end diastolic velocity (EDV) and resistance index (RI) of clitoral cavernosal arteries were measured during AVSS in each patients. RESULTS: In the premenopausal volunteer group, PSV of clitoral arteries (mean SD) showed 38.7 +/- 9.7cm/sec, EDV 14.9 +/- 3.2cm/sec, RI 0.59 +/- 0.04, respectively. PSV of clitoral arteries decreased to 27.3 9.6cm/sec in sexual arousal disorder group, 18.1 +/- 6.5cm/sec in menopausal group. PSV significantly decreased in menopausal group (p<0.05) compared to the premenopausal volunteer group, but RI did not be changed significantly. CONCLUSIONS: These results suggest that clitoral duplex Doppler ultrasonography with AVSS may be used to evaluate clitoral arterial function in the female sexual dysfunction patients. However, further studies are needed in a large group to define normal clitoral blood flow parameters.
Arteries ; Clitoris ; Female ; Humans ; Sexual Dysfunctions, Psychological ; Ultrasonography, Doppler ; Ultrasonography, Doppler, Duplex* ; Volunteers